Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs >

22nd Century Group (XXII)

XXII RSS Feed
Add XXII Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Tamtam, KarinCA, PinkieSwear, TOB, jockinmikeg, Grape Ape
Search This Board:
Last Post: 10/25/2014 12:34:03 AM - Followers: 219 - Board type: Free - Posts Today: 2

22nd Century Group Inc.

 

data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wCEAAkGBhQQEBUSERQWFRUVEh8UFhIYGRUYGhgWGBUfFyAYGBgZGyYfIBojHBgWIjsgIycpLCwuGB8yNjAqNiYrLCoBCQoKDgwOFA8PFSkdHCUvKiktLTU1NSoyNSwpKyk1KjM1KikrKSw1KSw2KSksMywpKSo1MzUsNCk1KSkpLSwsNf/AABEIAG0BzAMBIgACEQEDEQH/xAAcAAEAAgIDAQAAAAAAAAAAAAAABgcEBQEDCAL/xABIEAABAwIDBQMHBgoKAwAAAAABAAIDBBEFEiEGBzFBURMiYQgjQnGBkaEUMlJiscEVFzU2U3Jzk9HwGCSCkqKys7TC03TD0v/EABoBAQEBAQEBAQAAAAAAAAAAAAABAgYFBAP/xAApEQEAAgECBQMDBQAAAAAAAAAAAQIEAxEFIUFR8BKx4XGR0RUiIzEy/9oADAMBAAIRAxEAPwC8UREBERAREQEREBERAWJi+KMpYJJ5TZkbC93WwHAeJ4e1Zaiu9GkdLhFU1gJIjD7Dm1jw8/AE+xBQ21m3lViMjnSSObHfuwNcQxo8QPnHxPwWtwXaKoopBJTSvjIN7AnKfBzD3SPWFrkRp6k2D2tGJ0bZ7BrwckrBwDwBe3gQQR6/BSJVZuBo3tpJ5D8184DfHIyxI9pt7CrTRl1VVS2KN0jzZrGl7j0a0XJ9wXmnbTeNU4jK7vujgv3IGktGXkX2+c4+Og5L0DtrRvmw6qjj1e6meGgczkOnt4e1eU0WGbhWNz0jxJTyvjcDfuuIB/WbwI8CF6O3cbafhSk7RwDZo3ZJWjhe1w4eDhy5EELzIro8nykeI6qU3yOexg6FzQSfcHN96EreRERBERAREQEREBERAREQEREBERAREQEREBERAREQEREBERAREQEREBERAREQEREBERARaPauKsMOagka2RuvZua1wkHQE8HfA/FVHNvWxJji1z2tc02LTE0EEciLcVN3342BfJrvS0fTr7L4RUJ+NvEP0jP3bE/G3iH6Rn7tibvq/RsjvX7/AAvtFVOxW9xz5Oyry0Bx7k4AaGn6LwNLfW5c+otUG+oV3efkY2pj29N4coixsRxGOnidNM8MjYMznngB/Hw5o+ZkrhwuLFULj+/KrfO40mSOEaMD2BziB6TiToT0HBa78dWJ/pIv3TUXZLdrNxXaSOkoJGsDjcwSXDWn6jgDp4EadVrcE3BzueDVzMZGDq2K7nkdASAB69fUtJ+OrE/0kX7pqyMP3t4tUStihcx8jzlawRNuT7+HjyQX1hmGR00LIYWhkcbcrWjkPvJ435rKWmwyaWmpO0xGZhe1ueWQAMYwfRHUDrxJ9yqDaPfjUuqHfIsscI0bnYHOd9Y34X6Ii+FVO2m5EVErp6F7YnPOZ0LwcmY6ksI1bfpYj1cFCfx1Yn+ki/dNT8dWJ/pIv3TUVt8J3CVLnj5TNFGy+vZ5nuI8LgAes+5XPgmCxUcDIIG5WMFgOJJ4lzjzJOt1Q9JvfxWaRscTmPe92VrGwtJJPIBXhszBVNp2/LpGyTO1cGNDWs+qLcbdUG2RERBERAREQEREBERAREQEREBERAREQEREBERAREQEREBERAREQEREBERAREQEREBERAUK2/3dsr2mWGzKkDjwEgHov8ejvYdOE1RH66OtfRvF6TtLyvV0j4XujkaWPabOaRYgrqXoHbnYKPEWZm2ZO0dyTkfqv6t8eI+BofEsMkppXRTMLHtNi0/aOoPULEw7PCzaZVeXK3WPOjGVhbvN5ZpS2mqiTBwZJxMXgerPs9Wir1Efvr6FNek0vHJ6ircWihhNRJI1sTW5zJfTLyII435W43XnXeHvEkxSXK27KZh83Fzcfpv+t4cveVrK/EZpadtOZXGJji5sRPdBP8+y56laEi3FaiXG5eHfGttbnHSfOoiLJw3DZKmVsMLC+R5s1o5n7gOvJV8jjDsOkqJWwwsL5HmzWjiT/Dx5L0JsTsRBgtM6eocztcl5Zz81jeORnh8XH2Bc7FbFU+CUzp53N7XJeac8GN+gz6vxcfYFU+8bePJicnZx3ZTMd3I+BeR6b/HoOXrRHO8feO/E5OzjuymY7us4F5Hpv+5vL1qEoiKLuo6N80jY4ml73uytY0XJJ5BKKifNI2KJpe97srWDUkleiN2+7dmGR9pLZ9S9vefxEYPoM+93P1Ijjdtu2Zhsfay2fVPb3ncRGD6DPvdz9SnKIiCIiAiIgIiICIiAiIgIiICIiAiIgIiICIiAiIgIiICIiAiIgIiICIiAiIgIiICIiAiIgIiICju2WxUWJRWd3ZWjzcwGo8D1aenuUiWJiuKxUsLpp3hkbBdzj9g6k8LDijenqW07Rak7TDzXjWCS0czoZ25XD3OHJzTzBWCtrt3vBkxKoDgMkMdxFHpex4uefpGw04D3k6eKUOFwsTDscHPrkxtPK3b8PtdFRTB3r6rvRH3aulTVrNLxvDAw/CpaiZsELC+R5s1g/nQDjfgF6E2M2Mp8EpXTzvb2uS81QeDR9BnPLf2uPsCqjYzap2HVPahge1wySNsM2S9+67iD8Dz8PjePvClxKXILx07D3Iubj9N9tCeg4D3laiXHZuDfGt3r0nzq43i7xpMTkyMuymYe5Hzefpv8eg5evVQxEVfALvoaF88jYoml73uytYNSSUoKCSeRsUTS973ZWsHEn+efJeit3O7iPDI88ln1L29+TkwH0GeHU8/VYIjjdxu3ZhkfaSWfUvHffyYD6DPDqefqU2RabavayDDKY1FSSGg5WtaLue46hrRca2BOpA0RG5RVDH5Q0YyvkoahkDnWbNdpvboCA0kdA5TjGd4tHS0DK9zy6KUDsg0XdISL5Q02sRY3va1jdBJkVRReUNGCx01DURwvNmzXBvbmAWgG3QOVqYbiUdTCyaFwfHI0PY4cwfX9iDJREQEUV3jbdDB6VlQYe2zzCLLnyWuxz73yn6FreK2myuO/LqOGqydn2rM+S+bLqRa9hfh0QbZFots9sIcLpTUT3OuVkbbZnvOoaL+AJvyAPqVXf0gqlrWzvw0imc6zZMzwD4B5ZlJ0PuQXci1mze0EVfSx1UBJZILgHQgg2LXDqCCFs0BERARR/bbbGPCqYVMzHvaZBHlZlvdwJv3iBbRZmzG0DK+kiqo2ua2UEhrrZhZxbrYkckG0REQEREBERARVJj2/VwqnU2HUjqosJBeC45i3QljGNJLR9I8ei3G7re9HikrqaWEwVDWlwbfM14bxsSAQ4fRPjqgsNERAREQEREBERARFXu2O9oYdiMdF8mMnaBh7TtMtu0eW/NyHhbqgsJERAREQEREBERARFh4vi8VJC6ed4ZGwXLj9gHMnhZAxbFoqWF007wyNguXH7AOZPCw4rzht/t/Lik3NkDD5uH/m/q8/DgOZPG3230uKTa3ZAw+ahv8A439Xn4cBzJiqKL7ilLTcL4WXhOEy1UzIIGF8jzYNH2k8gOJJ4I3W00mLVnaWVDOHDT3LsV1YXu6ocNw6X5aWuLmXnqDpltwEXMWPC2pPuVKvnjc93ZFxYHHLmADi2+hIGl7dFmYdZgcRjIj0X5W9/OwuuaEOGvsK7EUeneldSs1tG8S1EsRabFd2H4fJUStihYXyPOVrBxJ/h48lnSxBwsVc+5jBaSOmM0ThJUnSZxFnR/UaOTPH0vZYaiXI5+BbGn1V519vq2u7rdzHhked9n1Lx35OTR9Bnh1PP3BTREVeUKHbxt3YxlkLHTuhETnO0YH5i4Aa3cOFj71MVFt5G2gwqhdOAHSOPZwtPAyOBNz9UAE+y3NBAd9NTT0WD0+GB4dK3sw1tgCGRNsZHAcMx99zxsUwPdQ7EsEoI5pnQGPtZQ3IHXE0mZtwXC3dsf7S0O7XZmCvmOJ4vVRPLpC5kMksYL3A/OkaTowHQMtY26WBtDeFvDjw7DzUQOZK+R3ZQZXNc3PbUnKeDQCbdbDmghW/Ovp6XDKbDWuDpWGMhotdscUZZnI5ZuA669FqMcxmtwjAcLbDK+F8naOeLC+Vzu0aCHA2sHBN1+y9PVSfhPFqqJ73vL2QySx3c4G3aSgu4XGjOGnSwW08ourZLS0T4nte0yyWc0hwNmtBsRpxQaXa7Fccp6SnxKWsyRz5AyGI2yZoy9uduWxJa0k8dVIdud6VRHgtDLE4R1FYy7pAB3RGLPLRyJcR6rldW9z82sP/AFqf/aPUM2/gP4GwV/o9hK2/iXtP2A+5B97f0OKw4bTur5xPDPI2VoJLnxSdk6zS4jmx7tASLt9937qfyNR/sB/mKr7fdi8UmC0AY9pMkjJWgEG7G07mk+wvaPWrB3U/kaj/AGA/zFBXflLVJ/qUfLzj/aMg/ip9UbGsrsDhoc3Zg00ID8ubKWNa6+W4uTY8+agnlK0RLKOa3dDpIyehcGuHvyu9yk+M7cin2cjq6eVrZTTxMjPdd52zWublNwS2z7jlZBgYmHbK4I9kUvbSvqLRPcwNDXSNF+7mNw0McfWQodV1GN0+Gx4w7EHlr3Nd2B1sx7rNcQRkIJt3bcHBYm1mN1eIbOxVVY7OfwkWtcGtZ5vsbDRoA+eJNVlxbE4ezBIK+qqqwxva1pijdGR2hcQWsY6w7pDtL6BpQbfb7eZVHCsOrKWUwPnziUMAILmANIGYHTMCfatPtfiuOU1JT4lLWZGT5Q2GI2yZoy9uduWxJa0k8dVi7xqaCPBMMFL2vYmSZ7O2DQ+znXNw3Tjf2KT74vzcw/8AaQf7SRBqN6VXWVuEUde+Zop5I4xJTAcai8l5BpwsOF124HPiFDs3JVtqrRlkYpmNAzQ/1rK+9227wJ68V97X/mfQ/rx/+xZNZIDsS2xBsGA25H5bwKDc4DtbVSbLzVj5nGoa2Qtms24yvsNLW0HgtBhG3tc/Zurq3VDzPHWMjZLZl2tJiuLZbek7lzX1s5WsbsbUAvaD5xlrj5zpBZvrNxoo9gX5o13/AJ7PthQb7YXFMcxU00olIpYaholkzNYZQJA59wBd1mnLa1vbdbPdttjW/huow+tndKGiRjA4NHejeCCMoHFlypFuI/IsX7ST/UKgO9NxwnaCKvYO7LHnNvpZDA8Dxylp/tIN/u32urcRxuqDp3GkiMjmxWblsZMkbb2vwuePoqz9pKoxUVTIOLKaR49bYyfuVb+TphGShnqXDvTz5QerYx/9Of7lZW0FIZqSoiHGSnewet0Zb96ClfJ3dHC2vqpiGiNjA6Q+izvOcb9NB7gpTg1DgsmLitpqzNVSSuc2Jr25HOewg93JfW5PHioZuCkhlNdQ1FrVETfNklpc1uZrwCCDezhw149FrsEpaaLauOOit2DKnKyzi4aREOs4kkjNm1ug2OIbe4s7Gaqio5XSF00sMMZDLMAce8CR6LQdSbDjqthtdtniWD4dT0s0t62Z8j3z5hIWxB1mhpItck8eQaeumFsZ+eFR+3qPscufKOhLa2kkI7pgLR62ykn4Oag42kxDGcBdTVE1aahsvzonEuaHNAJjdm8D85tuBWz3qbw6qGpoTRzuiiqKVkxaA03zvPG4Po2C7fKMrmOpaMNcDnldI23NmQd4eHeCh29CExHCGv0LMMhDr8i06+5BP9/G19XQGk+STOi7QS58oac2Xs7cQeGY+9ajert9XUU9EKedzQ+jZK9lmkPeXa30vrw0sunykqtj30LWuaSGSuIBB7rjHlOnI2NjzstTvnlDarDnHg2hiJ9QfdBlbV45jeC1FPUVVUJRNd5iBvH3SC6IsygDRw1b7Dor9oasSxMlbwewPHqcLj7VSvlHYlHJFQtY5ri7PKLEHuFrAHacjyPOx6KfUm29Jh8NFSVUpZM+liysySOvdoYNWtIHeBGqCZrzzvk/OKm/Vg/1XL0MvPO+T84qb9WD/Vcg2+8LbbEYMebSUc1mu7JrIXBuQvkFu8bXtc348lqMW2jxfBsVgjqqwziQskcwG8bo3vLC3KWjKRZ3ADku/bn876f9tT/cvnf1+WqP9hH/ALh6De7yduK2XFY8Iw6XsXEta+UaEve3P86xIa1hB014rEwTabEsJxmKgrp3VUUzmNzkE27U5Wva4i4s7Qg6Wv4LXVnmdtQZNA6obYn69OA23tNlYeO70GU2LRYaKcyPkdG0yB4GQyutq3KT3QQ7ignqKPUe3tHNWuoWSk1DC4OjySCxYLu7xbl09akKAiLBxnGYqOF087wxjBcnqeQA5uPRBzjGMRUkLp53hjGC5J+AA5k9F5v2929lxSa5uyBh81Dfh9Z3V5+HAePG3m3kuKTXddkLD5qG/D6zurz8OA8YuiiIszB8Hlq5mwQML5HmwA6cyTyaOZRTCMIlq5mQQML5HmwaPiSeTRzJXoXZXZSmwGkfNM9ufLeaoP8AkZzy34Di4psvstS4DRulme3PlvNUHn9Rg45b6ADUlU3vA3gy4pLbVlOw+bi/5v6uPuHAcySOd4O8KTFJbC7Kdh83F1+u/q77OHUmJNcQbhcIjUTMTvDZU9SHevou9YGFYbLUzMhgaXyPNmtH2+AHG54Kd7V7tqjD4mSuIlZlHaPaCMj+hH0b8He+2izMOp4fxKNXbT1Z/d0nv8oms7BMblo5mzQOyuHucObXDmCsFFl7NqxaJiY3h6L2N20ixKK7e7K0echJ1HiOrT196kS8uYZiclNK2aF5Y9puHD7COYPQ8VfGw+3seIx5TZk7R34uv1mdW+HEfFbiXJcQ4bOhM6mnzr7fCVqMbb7v4MXZGyofK0ROLm9m5rblwA1zMd0+JUnRV46q/wCjnh36Wq/vxf8AUtnV7k6OSkhpHSVAjge97SHR5iZSCcx7O2lhawCsFEFV/wBHPDv0tV/fi/6ltq7cxRzUUFEZKgR073vY4OjzEym5zEx2t0sAp8iCLbR7vIK6hhoZXytjgLC1zCwPPZxmMZiWkcHHgBquqv3ZUs+Gx4dIZDHCPNy3b2jXC/evly8yLWtZS5EFVU3k7UIjc18s7nFwIkBjaWgX7oGUjW+pNzoLW1vYmz+CMoqaKmiLnMiZkaXWLiL31sAL69FsUQa3aHZ2Cvp3U9SzPG7XoQRwc08nDr/FVtH5ONGJLmoqCy98nmwfUXBv3K20QaWo2OpX0PyAxD5PkDBGLi1jcEHjmvrfjdQKLydqMPGaoqXRB2YREsH+IN59QAVa6IIjtZuypcRggp3mSKOnBEbYiwWBaG2OZrtAAF3bS7vYK+ihopXytjhLC1zCwOPZxujFyWkcHHgBqpQiCL1e7umlwxmGvMhhYAGvu0SAtJIdcNtfU8rarUYDuYo6SGphzzSsqoxG8PLNA05gWlrBZwNjc34BT9EFVUHk70LC8ySzyZmlrQSxuS4tm0bq4cr6eC3lJuipY8Olw5sk/ZTTCZzi6POHNy6A5LW7g5dVOUQabZLZaLDKVtLC57mNc5wLy0uu43Ny0AfBUpvx2ugxCaKjp45HT08743EtGpNm5GWJLruA9wXoRYrMKha8yNijDybl4Y0OJPPNa90Gs2GwH5Dh1PTH50cQz/tHd93+JzlvURBWW0W4Siqp3TsklgL3ZnsZkLLk3JaHC7b9L28Fn4NuXoqSpp6mF0wfTjQZmEPdr3n9y9+9yIGg0U+RBDsM3X01PiT8SZJMZnue4sJZkvLe9gGA8+q2W2WxNPisAhqQe6czJGkB7HWtcEgix5ggg6dAt+iCr8I3AUcUzJJpZqgRkZYnloZobgOsLlvgCApDt5uzp8XbH2rnxyRAhkjMt8p9FwIsRz5W9pUvRBVw8nnD+yawyT5gSXSh0Yc64taxYQGjw66kqGb9KNrcSoYuLW0zGa82iUt1t4L0IsWqwuGVwdJFG9w4OcxriNb6Ejqgrmj8n2gjqRMXzOja/MKdxbl0N8rnWzFvhx6krX72MFZU4vhzIRI6pLmFzQPNsp2SFxedON83O1m8OCuBcZBe9tbWvzsg5UM2m3V02IVrK2WSZskYYA1hYG+bcXC4LCeJ6qZogh+K7sKapxJmIvkmErHMcGNLMl4+FwWE8uq42u3X02J1UdVNJM18TAxoYWBpDXl4uHMJvdx5qYoghu3O62lxZzZJS+OZgyiWMi5be4DgQQQCT0PisXY7c9S4dP8AKc8s84vlfIRZpIsXAAfOsSLklTxEERw7dlTQYk/EmPmMz3PcWlzMl5BY2AZfn1UuREGDjWNRUcDp53hjGDU8yeTWjm49F5u2727lxSbM67IWHzUN9APpO6vPXlwC+t4G2k2I1Lu07scT3MjhBuG2JbmPVxtx9iiyKIi4RWdg2DS1kzYIGF8jzoOQHNzjyaOZXoXZnZmlwCjfLK9ufLeaoPM8mMHHLfQNGpPisjd3sXDh9K0s70srGvkmIsTcXDR0aL8PaqW3mbZzV1W+N/digkcxkQOl2ktL3dXH4DQc7kdW3+8CXFJubIGHzcPwzv6vPw4DmTE0RFFlYVhUtVMyGBhfI82a0faTyA4kngsVekt2OxcNDSMlb35p42vfKRrZwDgxvRov7TqeViO/d/u+iwuHk+oePOS/HIzowfHieQErliDmlrgC0ixaRcEHQgjovpERSm8PdoaXNU0oLoOL4+Ji8R1Z9nq1Ver1YRfQqkt6WxsVJKyWDutmLrxW0a5trluugN+HL4LMw6jhvEZ1JjR1f76T+UAXbSVj4XtkicWPabtcNCCufk/j8E+T+PwWXuTMTyleewO8Rle0RS2ZUgat4CQD0mePVvu04TReW4WuY4OY4tc03DhcEEcwb8VfG7jaaSupSZgM8bsheNM+l8xHI/zotxLleJYEaP8ALp/57dvhLERFXiiIiAiIgIiICIiAiIgIiICIiAiIgIiICIiAiIgIiICIiAiIgIiICIiAiIgIiICIiD//2Q==


Ticker: XXII
(NYSE MKT)

Share Structure from latest 10-K:
O/S - 59,601,688 as of 8/11/14
Float - 39,500,000 as of 1/31/14

                                                                                                                                                                                                                                                                                                                        
                                                                                                                          
 
22nd Century is a plant biotechnology company whose proprietary technology through genetic engineering and plant breeding allows (i) the level of nicotine (and other nicotinic alkaloids) in the tobacco plant to be decreased or increased and (ii) the levels of cannabinoids to be decreased or increased, in addition to the cannabinoid profile being tailored. 22nd Century owns or is the exclusive licensee of 129 issued patents in 78 countries plus an additional 51 pending patent applications, and 22nd Century has co-exclusive rights to another 16 patent applications. Goodrich Tobacco is focused on commercial tobacco products and potential less harmful cigarettes. Botanical Genetics is focused on novel, cannabis plant varieties and cannabis-based products for human health, well-being and nutrition, in addition to industrial products refined from cannabis. Hercules Pharmaceuticals is focused on X-22, a prescription smoking cessation aid in development.

Editorial Opinion: "Patented and BAT-licensed altered nicotine technology that will disrupt a $700B Worldwide Tobacco Industry with 5 different revenue streams on both the consumer product and pharmaceutical side of smoking cessation, cannabis, and modified risk tobacco products - $1B+ mkt cap potential"
 

www.xxiicentury.com

XXII PIPELINE                               XXII TECHNOLOGY                            XXII PRODUCTS



 

Research and Recent News:



Chardan Capital Markets Analyst Reports 1/10/14    1/31/14    2/10/14   3/17/14    4/2/14    4/21/14    7/15/14


XXII RESEARCH REPORT - HTFBSN "Light This Fuse"


HTFBSN 22nd Century Group CEO Interview - November 2013
 

22nd Century Group to Acquire Participating Member of the Tobacco Master Settlement Agreement (MSA) - Sept 18, 2013
 

British American Tobacco Licenses 22nd Century Group Technology - Oct 1, 2013

22nd Century Group Warrant Exchange Eliminates 93% of Warrant Liability - Dec 16, 2013


22nd Century Group Files Annual Report and Provides Business Update - Jan. 30, 2014


22nd Century Group Approved to List Common Stock in NYSE MKT - Mar. 6, 2014


22nd Century Subsidiary Goodrich Tobacco Company Granted Federal Permit to Manufacture Tobacco Products - Mar. 10, 2014


22nd Century Group Files $45M Shelf Registration and Provides Business Update - Apr. 21, 2014


22nd Century Group Signs Letter of Intent w/ European Factory for Production of Nicotine-Free Cigarettes in Europe - May 29, 2014


22nd Century Group Added to Russell 3000, 2000, Global, and Microcap Indexes - Jun. 30, 2014


22nd Century Group Engages CRO for FDA Regulatory Activities for Company's Modified Risk Cigarettes - Jul. 11, 2014


22nd Century Group Partner NASCO Enters Agreement with Smoker Friendly International - Aug. 29, 2014


22nd Century Group Becomes Member of Tobacco Master Settlement Agreement (MSA) - Sep. 2, 2014


22nd Century Enters Cannabis Space - Sep. 18, 2014


22nd Century Granted Meeting w/FDA to Advance Development of a Potential Modified Risk Cigarette - Sep. 25, 2014


XXII Current Stock Chart:


 To learn more about 22nd Century Brands
Visit the links and images below:
         
                      GOLD MAGIC CIGARETTES                                                                                                    RED SUN CIGARETTES





 

                                                                    Home Dutch-

 
 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
XXII
Current Price
Volume:
Bid Ask Day's Range
Wiki
News News Alert: Notice of Effectiveness (effect) 10/24/2014 06:02:01 AM
PostSubject
#15054  Sticky Note XXII responds to SA article vangorilla 08/27/14 03:24:26 PM
#13282  Sticky Note 22nd Century Group Added to Russell 3000, Russell TOB 07/01/14 12:20:30 PM
#4398  Sticky Note $XXII: BUY Recommendation $9 Target - Chardan Capital Report jockinmikeg 01/11/14 12:02:04 AM
#18548   " Typically, if the days to cover stretch nick31 10/25/14 12:34:02 AM
#18547   Kinda expected that.. well one nice day they nick31 10/25/14 12:01:02 AM
#18546   The short interest increased for 10/15 report..Now over strut1702 10/24/14 11:50:49 PM
#18543   Well all I asked is if you know mtgbrokerbarbara 10/24/14 07:09:38 PM
#18542   My statistics? Took two semesters and one of streamingeagle88 10/24/14 06:51:04 PM
#18541   Did the bottom just get lower today ? mtgbrokerbarbara 10/24/14 06:29:19 PM
#18540   strongly agree... one thing i have learned from macnqueso 10/24/14 06:28:56 PM
#18538   bell ringing and dinner were purely ceremonial... nothing macnqueso 10/24/14 06:24:41 PM
#18533   Ha Ha SE, trying to answer a lot breewski 10/24/14 04:53:52 PM
#18532   It is becoming so ugly but this is selinpinar 10/24/14 04:47:39 PM
#18531   JustFM (no AM) streamingeagle88 10/24/14 04:46:49 PM
#18530   The big boys IMO are picking this clean, petemantx 10/24/14 04:39:56 PM
#18529   LOL, I remember a while back when you Grape Ape 10/24/14 04:29:20 PM
#18528   It definitely seems peculiar to me that HTFBS breewski 10/24/14 04:11:37 PM
#18527   Short interest numbers due out today. Should be interesting. weege 10/24/14 03:56:04 PM
#18526   If we have those other guys on board, petemantx 10/24/14 03:51:20 PM
#18525   Joe should deliver on what he hinted to strut1702 10/24/14 03:35:40 PM
#18524   Funds should be coming in at this point...but Justfactsmam 10/24/14 03:22:41 PM
#18523   1.50 here we come swilson 10/24/14 03:06:55 PM
#18522   Finally a poster who sees what has materialized jockinmikeg 10/24/14 02:27:14 PM
#18521   You mean there IS a Tommorow.. Giovanni 10/24/14 02:27:03 PM
#18520   The snooze button has been hit - wake aud722003 10/24/14 02:26:55 PM
#18519   Shipping product, MSA, revenues, China and FDA meeting streamingeagle88 10/24/14 02:19:53 PM
#18518   The additional shares you see are what Crede jockinmikeg 10/24/14 02:15:09 PM
#18517   Yep buy the dips now and next mtgbrokerbarbara 10/24/14 01:43:44 PM
#18516   Imo XXII increased OS to issue shares to Crede. nick31 10/24/14 01:40:54 PM
#18515   Open market, doesn't make sense. Can you elobrate selinpinar 10/24/14 01:40:03 PM
#18514   Didn't Crede invested 10mil? Where do you think nick31 10/24/14 01:38:12 PM
#18513   Last week total OS were 60million as per selinpinar 10/24/14 01:26:44 PM
#18512   Another article fyi. nick31 10/24/14 12:57:26 PM
#18511   Yep. All this stock does is drop. And Grape Ape 10/24/14 12:21:35 PM
#18510   Buying the dips tombrady12nh 10/24/14 12:15:55 PM
#18509   It's a just a number on a screen gary122 10/24/14 12:03:50 PM
#18508   Thank you! KraFtaVerK 10/24/14 11:47:43 AM
#18507   Save the PR... All that's gonna do is ztockings 10/24/14 11:37:49 AM
#18506   Day by day XXII slowly declines into irrelevancy. bababooyah 10/24/14 11:34:44 AM
#18505   So how are we feeling? I think Joe tombrady12nh 10/24/14 10:59:53 AM
#18504   Another bloody week... selinpinar 10/24/14 10:49:27 AM
#18503   Gio great article this a.m. TTommy 10/24/14 10:32:41 AM
#18501   TT Big tabbacy has beeninterested in MJ since Giovanni 10/24/14 10:15:20 AM
#18500   One has to be extremely disoriented to... TTommy 10/24/14 10:06:38 AM
#18499   Good for you...that's what makes the world go ARBITRARY & CAPRICIOUS 10/24/14 10:01:26 AM
#18494   Authorized common stock is the max amt of jockinmikeg 10/24/14 09:19:23 AM
#18492   Well said... Warrenesque... thanks for taking the time... #xxiiismonsantoesque macnqueso 10/24/14 07:15:36 AM
#18491   Anyone?: KraFtaVerK 10/24/14 05:08:26 AM
#18490   Thanks for the advice. I don't think ztockings 10/24/14 04:25:11 AM
#18489   The only Sykes students who make money are jockinmikeg 10/23/14 10:49:24 PM
#18488   You are far too intelligent for this board. streamingeagle88 10/23/14 09:33:36 PM
#18482   Scam....where did I suggest it's a scam....listen everyone ARBITRARY & CAPRICIOUS 10/23/14 08:18:29 PM
#18481   If xxii is scam from the beginning, why nick31 10/23/14 08:00:33 PM
PostSubject